Status:
COMPLETED
Temporal Dynamics of Irisin
Lead Sponsor:
Aksaray University Training and Research Hospital
Conditions:
Irisin
Lactate
Eligibility:
MALE
18-25 years
Phase:
NA
Brief Summary
Purpose The purpose of this study was to determine the peak point of irisin following exercises of different intensities. Method This randomized crossover controlled trial aimed to examine the acute ...
Eligibility Criteria
Inclusion
- Aged between 18 and 25 years
- No known medical condition that prevents participation in exercise
- Not currently using any pharmacological agents
Exclusion
- Experiencing any discomfort before, during, or after exercise
- Current or past diagnosis of pharmacological or doping substance use
- Engaging in regular exercise (more than 3 times per week) within the last 2 weeks
- History of alcohol or substance addiction
- Any other condition or factor that may prevent full participation in the study protocol
Key Trial Info
Start Date :
July 29 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2025
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT07191015
Start Date
July 29 2025
End Date
September 15 2025
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aksaray University
Aksaray, Center, Turkey (Türkiye), 68000